The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Hemolytic Uremic Syndrome
Abstract
Hemolytic uremic syndrome (HUS) is a disease of nonimmune (Coombs negative) hemolytic anemia, low platelet count, and renal impairment (1). Anemia is severe and microangiopathic in nature, with fragmented red blood cells (schistocytes) in the peripheral smear, high serum lactate dehydrogenase (LDH), circulating free hemoglobin, and reticulocytes. Platelet count is <60,000/mm3 in most cases (1). In children, the disease is most commonly triggered by Shiga-like toxin (Stx)-producing Escherichia coli (Stx-E. coli) and manifests with diarrhea (D+HUS), often bloody. Cases of Stx-E. coli HUS—approximately 25% (2)—which, however do not present with diarrhea, have also been reported (3). Acute renal failure manifests in 55 to 70% of cases (4–6); however, renal function recovers in most of them (up to 70% in various series) (1,3,6,7). Non–Shiga toxin-associated HUS (non–Stx-HUS) comprises a heterogeneous group of patients in whom an infection by Stx-producing bacteria could be excluded as cause of the disease. It can be sporadic or familial (i.e., more than one member of a family affected by the disease and exposure to Stx-E. coli excluded). Collectively, non–Stx-HUS forms have a poor outcome. Up to 50% of cases progress to ESRD or have irreversible brain damage, and 25% may die during the acute phase of the disease (8–10). Genetic studies have recently documented that the familial form is associated with genetic abnormalities of complement regulatory proteins, and evidence is now emerging that similar genetic alterations can predispose to sporadic cases of non–Stx-HUS as well. Major recent advances in the field of Stx-HUS and non–Stx-HUS are summarized in Table 1. Microvascular lesion of HUS consists of vessel wall thickening with endothelial swelling and accumulation of proteins and cell debris in the subendothelial layer, creating a space between endothelial cells and the underlying basement membrane of affected microvessels (1,3). In Stx-HUS, the lesion is mainly confined to the glomerular tuft and is noted in an early phase of the disease. Examination of biopsies taken several months after the disease onset showed that most glomeruli are normal, whereas 15 to 20% eventually became sclerotic (11,12). Arterial thrombosis does occur but is uncommon and seems to be a proximal extension of the glomerular lesion (11,12). Stx-Associated HUS Epidemiology In 70% of cases in North America and Western Europe, Stx-HUS is secondary to infection with the E. coli serotype O157:H7 (13–19). This serotype has a unique biochemical property (lack of sorbitol fermentation) as to render it readily distinguishable from other fecal E. coli (20). However, many other E. coli serotypes (O111:H8, O103:H2, O121, O145, O26, and O113 [13,16,21–23]) have been shown to cause Stx-HUS. Infection by Stx-producing Shigella dysenteriae serotype 1 has been commonly linked to Stx-HUS in developing countries of Asia (24) and Africa (25) but rarely in industrialized countries (26). After exposure to Stx-E. coli, 38 to 61% of individuals develop hemorrhagic colitis and 3 to 9% (in sporadic infections) to 20% (in epidemic forms) progress to overt HUS (5,27). The overall incidence of Stx-HUS is estimated to be 2.1 cases per 100,000 persons/yr, with a peak incidence in children who are younger than 5 yr (6.1 per 100,000/yr), and the lowest rate in adults who are 50 to 59 yr of age (0.5 per 100,000/yr) (1). The incidence of the disease parallels the seasonal fluctuation of E. coli O157:H7 infections with a peak in warmer months, between June and September. In the United States, approximately 70,000 illnesses and 60 deaths have been attributed annually to Stx-HUS (28). In Argentina and Uruguay, E. coli infections are endemic and Stx-HUS is a common cause of acute renal failure in children (23,29,30), with an estimated incidence rate of 10.5 per 100,000/yr (31). An association between traditional extensive production of cattle with endemic HUS in Argentina has been proposed, as supported by detection of Stx-producing E. coli strains—mainly O8, O25, O103, O112, O113, O145, O171, and O174 serotypes—in stool samples from 39% of Argentine healthy young beef steers (31). Stx-producing E. coli colonize healthy cattle intestine but also have been isolated from deer, sheep, goats, horses, dogs, birds, and flies (1,32). They are found in manure and water troughs in farms, which explains the increased risk for infection in people who live in rural areas. Humans become infected from contaminated milk, meat, and water—water-borne outbreaks have occurred as a result of drinking and swimming in unchlorinated water (21)—or from contact with infected animals, humans, or either’s excreta (27,33,34) and occasionally through environmental contamination (17). Meat is contaminated at slaughter. Internalization of the microorganism during grinding renders it capable of surviving cooking (27). Fruits and vegetables may also be contaminated, including radish sprouts, lettuce, and ap
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Food-Related Illness and Death in the United States
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C., Griffin, P. M., & Tauxe, R. V. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990502 · Cited by 7,235
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Hemorrhagic Colitis Associated with a Rare Escherichia coli Serotype
Riley, L. W., Remis, R. S., Helgerson, S. D., McGee, H. B., Wells, J. G., Davis, B. R., Hebert, R. J., Olcott, E. S., Johnson, L. M., Hargrett, N. T., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303243081203 · Cited by 2,668
Griffin, P. M., & Tauxe, R. V. (1991) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036079 · Cited by 1,807
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
Tarr, P. I., Gordon, C. A., & Chandler, W. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71144-2 · Cited by 1,774
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
Tsai, H.-M., & Lian, E. C.-Y. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392203 · Cited by 1,760
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,481
Vero response to a cytotoxin of Escherichia coli
Konowalchuk, J., Speirs, J. I., & Stavric, S. (1977) · Infection and Immunity · doi:10.1128/iai.18.3.775-779.1977 · Cited by 1,149
Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L., & Tarr, P. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422601 · Cited by 1,094
Karmali, M., Petric, M., Steele, B., & Lim, C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91795-6 · Cited by 1,035
Mead, P. S., & Griffin, P. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01267-7 · Cited by 1,027
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Self-citationVesely, S. K., George, J. N., Lämmle, B., Studt, J.-D., Alberio, L., El-Harake, M. A., & Raskob, G. E. (2003) · Blood · doi:10.1182/blood-2003-01-0193 · Cited by 676
Hillmen, P., Hall, C., Marsh, J. C. W., Elebute, M., Bombara, M. P., Petro, B. E., Cullen, M. J., Richards, S. J., Rollins, S. A., Mojcik, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031688 · Cited by 635
The human complement factor H: functional roles, genetic variations and disease associations
RODRIGUEZDECORDOBA, S., ESPARZAGORDILLO, J., GOICOECHEADEJORGE, E., LOPEZTRASCASA, M., & SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.02.005 · Cited by 574
Gasser, C., GAUTIER, E., STECK, A., SIEBENMANN, R. E., & Oechslin, R. (1955) · PubMed · Cited by 553
A Severe Outbreak of Escherichia coli O157:H7–Associated Hemorrhagic Colitis in a Nursing Home
Carter, A. O., Borczyk, A. A., Carlson, J. A. K., Harvey, B., Hockin, J. C., Karmali, M. A., Krishnan, C., Korn, D. A., & Lior, H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712103172403 · Cited by 536
Garg, A. X., Suri, R. S., Barrowman, N., Rehman, F., Matsell, D., Rosas-Arellano, M. P., Salvadori, M., Haynes, R. B., & Clark, W. F. (2003) · JAMA · doi:10.1001/jama.290.10.1360 · Cited by 514
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
Ruggenenti, P., Noris, M., & Remuzzi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003831.x · Cited by 489
Self-citationde Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
An Outbreak of Escherichia coli O157:H7 Infection from Unpasteurized Commercial Apple Juice
Cody, S. H., Glynn, M. K., Farrar, J. A., Cairns, K. L., Griffin, P. M., Kobayashi, J., Fyfe, M., Hoffman, R., King, A. S., Lewis, J. H., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-3-199902020-00005 · Cited by 428
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Platelet activation leads to activation and propagation of the complement system
del Conde, I., Crúz, M. A., Zhang, H., López, J. A., & Afshar-Kharghan, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041497 · Cited by 397
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice
Tesh, V. L., Burris, J. A., Owens, J. W., Gordon, V. M., Wadolkowski, E. A., O'Brien, A. D., & Samuel, J. E. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3392-3402.1993 · Cited by 392
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias
Allford, S. L., Hunt, B. J., Rose, P., Machin, S. J., & on behalf of the Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04049.x · Cited by 383
Dragon-Durey, M.-A., Frémeaux-Bacchi, V., Loirat, C., Blouin, J., Niaudet, P., Deschenes, G., Coppo, P., Herman Fridman, W., & Weiss, L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115702.28859.a7 · Cited by 355
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Self-citationRole of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
Donnenberg, M. S., Tacket, C. O., James, S. P., Losonsky, G., Nataro, J. P., Wasserman, S. S., Kaper, J. B., & Levine, M. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116717 · Cited by 343
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
Fremeaux-Bacchi, V, Dragon-Durey, M.-A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E., & Fridman, W. H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019083 · Cited by 339
Keene, W. E., McAnulty, J. M., Hoesly, F. C., Williams, L. P., Hedberg, K., Oxman, G. L., Barrett, T. J., Pfaller, M. A., & Fleming, D. W. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409013310904 · Cited by 328
A New Family of Potent AB5 Cytotoxins Produced by Shiga Toxigenic Escherichia coli
Paton, A. W., Srimanote, P., Talbot, U. M., Wang, H., & Paton, J. C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040392 · Cited by 324
Granger, C. B., Mahaffey, K. W., Weaver, W. D., Theroux, P., Hochman, J. S., Filloon, T. G., Rollins, S., Todaro, T. G., Nicolau, J. C., Ruzyllo, W., et al. (2003) · Circulation · doi:10.1161/01.cir.0000087447.12918.85 · Cited by 323
Banatvala, N., Griffin, P. M., Greene, K. D., Barrett, T. J., Bibb, W. F., Green, J. H., & Wells, J. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/319269 · Cited by 312
Structure of Shiga Toxin Type 2 (Stx2) from Escherichia coli O157:H7
Fraser, M. E., Fujinaga, M., Cherney, M. M., Melton-Celsa, A. R., Twiddy, E. M., O'Brien, A. D., & James, M. N. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401939200 · Cited by 311
Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Self-citationCrystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution
Fraser, M. E., Chernaia, M. M., Kozlov, Y. V., & James, M. N. G. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0194-59 · Cited by 299
Endothelial heterogeneity in Shiga toxin receptors and responses
Obrig, T. G., Louise, C. B., Lingwood, C. A., Boyd, B., Barley-Maloney, L., & Daniel, T. O. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82282-7 · Cited by 295
Pérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
Safdar, N., Said, A., Gangnon, R. E., & Maki, D. G. (2002) · JAMA · doi:10.1001/jama.288.8.996 · Cited by 293
CAPRIOLI, J., BETTINAGLIO, P., ZIPFEL, P. F., AMADEI, B., DAINA, E., GAMBA, S., SKERKA, C., MARZILIANO, N., REMUZZI, G., & NORIS, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122297 · Cited by 286
Self-citationEsparza-Gordillo, J., Jorge, E. G. D., Buil, A., Berges, L. C., López-Trascasa, M., Sánchez-Corral, P., & Córdoba, S. R. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi066 · Cited by 281
Besbas, N., Karpman, D., Landau, D., Loirat, C., Proesmans, W., Remuzzi, G., Rizzoni, G., Taylor, C. M., Van de Kar, N., & Zimmerhackl, L. B. (2006) · Kidney International · doi:10.1038/sj.ki.5001581 · Cited by 277
Self-citation(2012) · SpringerReference · doi:10.1007/springerreference_226547 · Cited by 267
Glanantonio, C. A., Vltacco, M., Mendilaharzu, F., Gallo, G. E., & Sojo, E. T. (1973) · Nephron · doi:10.1159/000180229 · Cited by 262
Tarr, P. I., Neill, M. A., Clausen, C. R., Watkins, S. L., Christie, D. L., & Hickman, R. O. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.2.553 · Cited by 242
Ake, J. A., Jelačić, S., Ciol, M. A., Watkins, S. L., Murray, K. F., Christie, D. L., Klein, E. J., & Tarr, P. I. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2236 · Cited by 229
van Setten, P., Monnens, L., Verstraten, R., van den Heuvel, L., & van Hinsbergh, V. (1996) · Blood · doi:10.1182/blood.v88.1.174.174 · Cited by 223
Paton, A. W., Morona, R., & Paton, J. C. (2000) · Nature Medicine · doi:10.1038/73111 · Cited by 222
Thrombotic microangiopathy after renal transplantation in the United States
Reynolds, J. C., Agodoa, L. Y., Yuan, C. M., & Abbott, K. C. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.008 · Cited by 219
Sánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., López-Trascasa, M., & de Córdoba, S. R. (2002) · The American Journal of Human Genetics · doi:10.1086/344515 · Cited by 218
Sm, O. (1989) · JAMA · doi:10.1001/jama.262.3.355 · Cited by 218
An Outbreak of Escherichia coli O157:H7 Infections among Visitors to a Dairy Farm
Crump, J. A., Sulka, A. C., Langer, A. J., Schaben, C., Crielly, A. S., Gage, R., Baysinger, M., Moll, M., Withers, G., Toney, D. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020524 · Cited by 212
Louise, C. B., & Obrig, T. G. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.5.1397 · Cited by 208
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.
Thompson, R. A., & Winterborn, M. H. (1981) · PubMed · Cited by 207
Neumann, H. P. H., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B. U., Cybulla, M., Riegler, P., Königsrainer, A., et al. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.9.676 · Cited by 206
The pathogenesis and treatment of hemolytic uremic syndrome.
Kaplan, B. S., Meyers, K. E., & Schulman, S. L. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961126 · Cited by 203
Hemolytic Uremic Syndrome in Families
Kaplan, B. S., Chesney, R. W., & Drummond, K. N. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505222922102 · Cited by 196
Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells
O’Loughlin, E. V., & Robins-Browne, R. M. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01405-8 · Cited by 192
Shiga Toxin--Producing Escherichia coli Infection
Thorpe, C. M. (2004) · Clinical Infectious Diseases · doi:10.1086/383473 · Cited by 190
SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.01.003 · Cited by 180
Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome
Cimolai, N., Carter, J. E., Morrison, B. J., & Anderson, J. D. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81609-9 · Cited by 176
Prothrombotic Coagulation Abnormalities Preceding the Hemolytic–Uremic Syndrome
(2002) · New England Journal of Medicine · doi:10.1056/nejm200202283460923 · Cited by 175
LOCKING, M. E., O'BRIEN, S. J., REILLY, W. J., WRIGHT, E. M., CAMPBELL, D. M., COIA, J. E., BROWNING, L. M., & RAMSAY, C. N. (2001) · Epidemiology and Infection · doi:10.1017/s0950268801006045 · Cited by 172
Fremeaux-Bacchi, V, Kemp, E. J., Goodship, J. A., Dragon-Durey, M.-A., Strain, L., Loirat, C., Deng, H.-W., & Goodship, T. H. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030783 · Cited by 171
Hurley, B. P., Thorpe, C. M., & Acheson, D. W. K. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6148-6155.2001 · Cited by 169
Localization of the complement regulatory proteins in the normal human kidney
Ichida, S., Yuzawa, Y., Okada, H., Yoshioka, K., & Matsuo, S. (1994) · Kidney International · doi:10.1038/ki.1994.247 · Cited by 165
Therapeutic Plasma Exchange: An Update from the Canadian Apheresis Group
Clark, W. F., Rock, G. A., Buskard, N., Shumak, K. H., LeBlond, P., Anderson, D., Sutton, D. M., & for the Canadian Apheresis Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-6-199909210-00011 · Cited by 163
Role of Membrane Cofactor Protein (CD46) in Regulation of C4b and C3b Deposited on Cells
Barilla-LaBarca, M. L., Liszewski, M. K., Lambris, J. D., Hourcade, D., & Atkinson, J. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6298 · Cited by 161
Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome
Siegler, R. L., Obrig, T. G., Pysher, T. J., Tesh, V. L., Denkers, N. D., & Taylor, F. B. (2003) · Pediatric Nephrology · doi:10.1007/s00467-002-1035-7 · Cited by 160
Varma, J. K. (2003) · JAMA · doi:10.1001/jama.290.20.2709 · Cited by 160
Takahashi, M., Taguchi, H., Yamaguchi, H., Osaki, T., Komatsu, A., & Kamiya, S. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.03.010 · Cited by 159
Complement factor H and related proteins: an expanding family of complement-regulatory proteins?
Zipfel, P. F., & Skerka, C. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90155-4 · Cited by 159
Liszewski, M. K., Leung, M. K., Cui, W., Subramanian, V. B., Parkinson, J., Barlow, P. N., Manchester, M., & Atkinson, J. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004650200 · Cited by 154
Karpman, D., Papadopoulou, D. N., Nilsson, K., Sjögren, A.-C., Mikaelsson, C. G., & Lethagen, S. (2001) · Blood · doi:10.1182/blood.v97.10.3100 · Cited by 149
Combined kidney and liver transplantation for familial haemolytic uraemic syndrome
Remuzzi, G., Ruggenenti, P., Codazzi, D., Noris, M., Caprioli, J., Locatelli, G., & Gridelli, B. G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08560-4 · Cited by 148
Self-citationPangburn, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4702 · Cited by 146
Richards, A., Liszewski, M. K., Kavanagh, D., Fang, C. J., Moulton, E. A., Frémeaux‐Bacchi, V., Remuzzi, G., Noris, M., Goodship, T. H. J., & Atkinson, J. P. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.004 · Cited by 131
Self-citationEsparza-Gordillo, J., de Jorge, E. G., Abarrategui-Garrido, C., CARRERAS, L., López‐Trascasa, M., Sánchez‐Corral, P., & de Córdoba, S. R. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.008 · Cited by 131
Zoja, C., Angioletti, S., Donadelli, R., Zanchi, C., Tomasoni, S., Binda, E., Imberti, B., Loo, D. M. W. M. T., Monnens, L. A. H., Remuzzi, G., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00503.x · Cited by 127
Self-citationDrug‐induced Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome: A Concise Review
Dlott, J. S., Danielson, C., Blue, D. E., & McCarthy, L. J. (2004) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1526-0968.2003.00127.x · Cited by 126
Letter: Allergy, immunodeficiency, and epilepsy.
As, C. (1975) · PubMed · Cited by 125
Ying, L., Katz, Y., Schlesinger, M., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302673 · Cited by 123
Hellwage, J., Jokiranta, T. S., Friese, M. A., Wolk, T., Kampen, E., Zipfel, P. F., & Meri, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6935 · Cited by 122
Matussek, A., Lauber, J., Bergau, A., Hansen, W., Rohde, M., Dittmar, K. E. J., Gunzer, M., Mengel, M., Gatzlaff, P., Hartmann, M., et al. (2003) · Blood · doi:10.1182/blood-2002-10-3301 · Cited by 112
Targeting complement in therapy
Kirschfink, M. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800116.x · Cited by 111
Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells
Hughes, A. K., Stricklett, P. K., & Kohan, D. E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00015.x · Cited by 109
Identification and quantification of complement regulator CD46 on normal human tissues.
Johnstone, R. W., Loveland, B. E., & McKenzie, I. F. C. (1993) · PubMed · Cited by 108
The British Paediatric Surveillance Unit.
Hall, S. M., & Glickman, M. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.3.344 · Cited by 108
Risk Factors for Sporadic Infection With Escherichia coli 0157:H7
Mead, P. S., Finelli, L., Lambert-Fair, M. A., Champ, D., Townes, J., Hutwagner, L., Barrett, T., Spitalny, K., & Mintz, E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.2.204 · Cited by 105
Morigi, M., Galbusera, M., Binda, E., Imberti, B., Gastoldi, S., Remuzzi, A., Zoja, C., & Remuzzi, G. (2001) · Blood · doi:10.1182/blood.v98.6.1828 · Cited by 102
Self-citationBitzan, M. M., Richardson, S. E., Huang, C., Boyd, B., Petrić, M., & Karmali, M. A. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3337-3347.1994 · Cited by 100
Brooks, J. T., Bergmire‐Sweat, D., Kennedy, M., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/380634 · Cited by 89
Familial hemolytic uremic syndrome associated with complement factor H deficiency
Landau, D., Shalev, H., Levy-Finer, G., et al. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112649 · Cited by 85
Józsi, M., Manuelian, T., Heinen, S., Oppermann, M., & Zipfel, P. F. (2004) · PubMed · doi:10.14670/hh-19.251 · Cited by 81
Tarr, P. I., & Neill, M. A. (2001) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70208-9 · Cited by 79
Lazar, H. L., Bokesch, P. M., van Lenta, F., Fitzgerald, C. A., Emmett, C., Marsh, H. C., Ryan, U. S., & OBE and the TP10 Cardiac Surgery Study Group (2004) · Circulation · doi:10.1161/01.cir.0000138315.99788.eb · Cited by 76
Verocytotoxin-Induced Apoptosis of Human Microvascular Endothelial Cells
PIJPERS, A. H. J. M., van Setten, P. A., van den Heuvel, L. P., Assmann, K. J. M., Dijkman, H. B. P. M., Pennings, A. H. M., Monnens, L. A. H., & van Hinsbergh, V. W. M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v124767 · Cited by 74
Endoh, M., Yamashina, M., Ohi, H., Funahashi, K., IKUNO, T., Yasugi, T., Atkinson, J. P., & Okada, H. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05998.x · Cited by 59
SHIGELLA AND SHIGA TOXIN-PRODUCING ESCHERICHIA COLI CAUSING BLOODY DIARRHEA IN LATIN AMERICA
López, E. L., Prado-Jiménez, V., O’Ryan, M., & Contrini, M. M. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70217-8 · Cited by 59
Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy
Gianviti, A., Rosmini, F., Caprioli, A., Corona, R., Matteucci, M. C., Principato, F., Luzzi, I., Rizzoni, G., & Italian HUS Study Group (1994) · Pediatric Nephrology · doi:10.1007/bf00869095 · Cited by 50
Refinement of a Therapeutic Shiga Toxin–Binding Probiotic for Human Trials
Pinyon, R. A., Paton, J. C., Paton, A. W., Botten, J. A., & Morona, R. (2004) · The Journal of Infectious Diseases · doi:10.1086/383417 · Cited by 39
Lepirudin prevents lethal effects of Shiga toxin in a canine model
Friedman, K. D., Fenwick, B. W., & Raife, T. J. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-12-0759 · Cited by 31
Two different therapeutic regimes in patients with sequelae of hemolytic-uremic syndrome
Caletti, M. G., Lejarraga, H., Kelmansky, D., & Missoni, M. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1516-y · Cited by 29
Cited by
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Self-citationComplement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
Goodship, T. H. J., Cook, H. T., Fakhouri, F., Fervenza, F. C., Frémeaux-Bacchi, V., Kavanagh, D., Nester, C. M., Noris, M., Pickering, M. C., Rodríguez de Córdoba, S., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.10.005 · Cited by 701
Self-citationAtypical hemolytic uremic syndrome
Loirat, C., & Frémeaux-Bacchi, V. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-60 · Cited by 669
Thrombomodulin Mutations in Atypical Hemolytic–Uremic Syndrome
Delvaeye, M., Noris, M., De Vriese, A., Esmon, C. T., Esmon, N. L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810739 · Cited by 554
Self-citation
Metadata
- Authors
- Noris, M., & Remuzzi, G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-04
- Volume
- 16
- Issue
- 4
- Pages
- 1035-1050
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2129781700
- Cited by
- 635
- References
- 107
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.